About
About Yield10 Bioscience Inc
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts. On December 6, 2024, Yield10 Bioscience, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Visit company website
5 years, 4 months ago
Yield10 Bioscience, Inc is currently in a long term downtrend where the price is trading 14.5% below its 200 day moving average.
From a valuation standpoint, the stock is 296.5% more expensive than other stocks from the Basic Materials sector with a price to sales ratio of 39.0.
Yield10 Bioscience, Inc's total revenue rose by 39.3% to $195K since the same quarter in the previous year.
Its net income has increased by 61.4% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 27.7% to $-2M since the same quarter in the previous year.
Based on the above factors, Yield10 Bioscience, Inc gets an overall score of 3/5.